As we have expected, miR-34a high expression tumors demonstrated lower expression levels of EMT inducing factor, Notch-1, in whole METABRIC cohorts, as well as in all the subtypes of breast cancer patients (p < 0.001, p < 0.001, p < 0.05, and p < 0.01, respectively; Figure 5). The gene discussed is NOTCH1; the disease is breast carcinoma.